Ignite Creation Date:
2025-12-24 @ 3:02 PM
Ignite Modification Date:
2026-03-05 @ 12:30 AM
Study NCT ID:
NCT02309359
Status:
COMPLETED
Last Update Posted:
2019-08-21
First Post:
2014-11-27
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid Arthritis
Sponsor:
Ablynx, a Sanofi company
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Rheumatoid Arthritis | View |
Keywords: